Archive for September, 2016

George Will on settlement slush funds

George Will’s new column is on settlement slush funds, a favorite topic around here. A Wall Street Journal op-ed the other day by Andy Koenig observed that tens of millions of dollars from settlements with big banks by the Obama Department of Justice and New York Attorney General Eric Schneiderman are being directed to liberal political groups allied with Obama and Schneiderman, rather than to customers or taxpayers. Earlier here, here, here, here, here, etc.

“Scott Alexander” on the EpiPen affair

“When was the last time that America’s chair industry hiked the price of chairs 400% and suddenly nobody in the country could afford to sit down?” Funny, isn’t it, how these episodes keep happening in a sector of the economy where a new competitor, before being allowed to enter even a well-understood generic market, faces the prospect of unpredictable and expensive government denials and delays? [Scott Alexander]

More: Scott Gottlieb on how the new, more ardently regulatory FDA keeps generic drugs (and devices) off the market. Don’t blame the patent angle; EpiPen is off-patent [Timothy Holbrook, The Conversation]

Bears in Yellowstone: eat, sue, warn

“The decision was reversed on appeal, but it spooked the Park Service into trying to lawyer-proof Yellowstone. Walker’s folks insisted that there was no way their son could have known about the danger of bears, or hiking off trails, or pitching camp in the middle of nowhere, or leaving food and trash next to his tent. So officials in Yellowstone set out to make sure that you’d have to be dumb as a rock not to understand the risks of the park. And they got the job done.” [Jonathan Last, Weekly Standard]

Schools roundup